Clinical Findings and Outcomes From Subjects With COVID-19 Pneumonia in an Intermediate Respiratory Care Unit.

BACKGROUND: Many patients with COVID-19 require respiratory support and close monitoring. Intermediate respiratory care units (IRCU) may be valuable to optimally and adequately implement noninvasive respiratory support (NRS) to decrease clinical failure. We aimed at describing intubation and mortali...

Descripción completa

Detalles Bibliográficos
Publicado en:Respiratory Care Vol. 68; no. 1; pp. 67 - 77
Autores principales: Laorden, Daniel, Gholamian-Ovejero, Soraya, Terán-Tinedo, José Rafael, Lorente-González, Miguel, Cano-Sanz, Eduardo, Ortega-Fraile, María Ángeles, Martínez-Alejos, Roberto, Hernández-Nuñez, Joaquín, De La Calle-Gil, Isabel, Navarro-Casado, Rosalía, Neria, Fernando, Zevallos-Villegas, Annette, Mariscal-Aguilar, Pablo, Suarez-Ortiz, Miguel, Plaza-Moreno, María Cristina, Carballo-López, Daniel, Gallego-Rodríguez, Berta, Calderón-Alcala, Mariara, Latif-Essa, Aylaf, Churruca-Arróspide, María
Formato: algorithm research tables/charts Journal Article
Publicado: Mary Ann Liebert, Inc. Jan2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=160923590&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 160923590
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00201324
        4GG
      jtl: Respiratory Care
      issn: 00201324
      maglogo: N
    pubinfo:
      dt: Jan2023
      vid: 68
      iid: 1
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        160923590
        160923590
        160923590
        10.4187/respcare.10193
        160923590
      ppf: 67
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Clinical Findings and Outcomes From Subjects With COVID-19 Pneumonia in an Intermediate Respiratory Care Unit.
      aug:
        au:
          Laorden, Daniel
          Gholamian-Ovejero, Soraya
          Terán-Tinedo, José Rafael
          Lorente-González, Miguel
          Cano-Sanz, Eduardo
          Ortega-Fraile, María Ángeles
          Martínez-Alejos, Roberto
          Hernández-Nuñez, Joaquín
          De La Calle-Gil, Isabel
          Navarro-Casado, Rosalía
          Neria, Fernando
          Zevallos-Villegas, Annette
          Mariscal-Aguilar, Pablo
          Suarez-Ortiz, Miguel
          Plaza-Moreno, María Cristina
          Carballo-López, Daniel
          Gallego-Rodríguez, Berta
          Calderón-Alcala, Mariara
          Latif-Essa, Aylaf
          Churruca-Arróspide, María
        affil: Intermediate Respiratory Care Unit, Isabel Zendal Emergency Hospital, Madrid, Spain
      sug:
        subj:
          COVID-19 Therapy
          Pneumonia Therapy
          Respiratory Care Units
          Intubation
          Mortality
          Outcomes (Health Care)
          Spain
          Human
          Female
          Male
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Retrospective Design
          Nonexperimental Studies
          Respiration, Artificial
          Cox Proportional Hazards Model
          Confidence Intervals
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Female
          Male
      ab: BACKGROUND: Many patients with COVID-19 require respiratory support and close monitoring. Intermediate respiratory care units (IRCU) may be valuable to optimally and adequately implement noninvasive respiratory support (NRS) to decrease clinical failure. We aimed at describing intubation and mortality in a novel facility entirely dedicated to COVID-19 and to establish their outcomes. METHODS: This was a retrospective, observational study performed at one hospital in Spain. We included consecutive subjects age > 18 y, admitted to IRCU with COVID-19 pneumonia, and requiring NRS between December 2020-September 2021. Data collected included mode and usage of NRS, laboratory findings, endotracheal intubation, and mortality at day 30. A multivariable Cox model was used to assess risk factors associated with clinical failure and mortality. RESULTS: A total of 1,306 subjects were included; 64.6% were male with mean age of 54.7 y. During the IRCU stay, 345 subjects clinically failed NRS (85.5% intubated; 14.5% died). Cox model showed a higher clinical failure in IRCU upon onset of symptoms and hospitalization was < 10 d (hazard ratio [HR] 1.59 [95% CI 1.24-2.03], P < .001) and PaO2 /FIO2 < 100 mm Hg (HR 1.59 [95% CI 1.27-1.98], P < .001). These variables were not associated with increased 30-d mortality. CONCLUSIONS: The IRCU was a valuable option to manage subjects with COVID-19 requiring NRS, thus reducing ICU overload. Male sex, gas exchange, and blood chemistry at admission were associated with worse prognosis, whereas older age, gas exchange, and blood chemistry were associated with 30-d mortality. These findings may provide a basis for better understanding outcomes and to improve management of noninvasively ventilated patients with COVID-19.
      pubtype: Academic Journal
      doctype:
        algorithm
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N